Correlation Between Kilitch Drugs and Rossari Biotech

Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and Rossari Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and Rossari Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kilitch Drugs Limited and Rossari Biotech Limited, you can compare the effects of market volatilities on Kilitch Drugs and Rossari Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of Rossari Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and Rossari Biotech.

Diversification Opportunities for Kilitch Drugs and Rossari Biotech

0.19

Correlation Coefficient

Kilitch Drugs  Rossari Biotech

Average diversification

The 3 months correlation between Kilitch and Rossari is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and Rossari Biotech Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rossari Biotech and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with Rossari Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rossari Biotech has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and Rossari Biotech go up and down completely randomly.

Pair Corralation between Kilitch Drugs and Rossari Biotech

Assuming the 90 days trading horizon Kilitch Drugs Limited is expected to generate 1.4 times more return on investment than Rossari Biotech. However, Kilitch Drugs is 1.4 times more volatile than Rossari Biotech Limited. It trades about 0.15 of its potential returns per unit of risk. Rossari Biotech Limited is currently generating about 0.14 per unit of risk. If you would invest  32,465  in Kilitch Drugs Limited on October 22, 2024 and sell it today you would earn a total of  2,200  from holding Kilitch Drugs Limited or generate 6.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Kilitch Drugs Limited  vs.  Rossari Biotech Limited

Kilitch Drugs Limited

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Kilitch Drugs Limited are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, Kilitch Drugs may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Rossari Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Rossari Biotech Limited are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Rossari Biotech is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Kilitch Drugs and Rossari Biotech

The main advantage of trading using opposite Kilitch Drugs and Rossari Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, Rossari Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rossari Biotech will offset losses from the drop in Rossari Biotech's long position.

The idea behind Kilitch Drugs Limited and Rossari Biotech Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.